.

Pharmaceutical Business Intelligence

  • Predict branded drug patent expiration
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

DrugPatentWatch Database Preview

ZANTAC 25 Drug Profile

« Back to Dashboard

Which patents cover Zantac 25, and what substitute generic drugs are available?

Zantac 25 is a drug marketed by Glaxo Grp Ltd and is included in one NDA.

The generic ingredient in ZANTAC 25 is ranitidine hydrochloride. There are forty-two drug master file entries for this compound. One hundred and forty-one suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.

Summary for Tradename: ZANTAC 25

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list6
Clinical Trials: see list4
Patent Applications: see list1,732
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZANTAC 25 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxo Grp Ltd
ZANTAC 25
ranitidine hydrochloride
TABLET, EFFERVESCENT;ORAL020251-003Apr 1, 2004DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc